KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Net Income: 2009-2024

Historic Net Income for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -$99.6 million.

  • Pacira BioSciences' Net Income rose 103.79% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 123.63%. This contributed to the annual value of -$99.6 million for FY2024, which is 337.30% down from last year.
  • Per Pacira BioSciences' latest filing, its Net Income stood at -$99.6 million for FY2024, which was down 337.30% from $42.0 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Net Income ranged from a high of $145.5 million in FY2020 and a low of -$99.6 million during FY2024.
  • Moreover, its 3-year median value for Net Income was $15.9 million (2022), whereas its average is -$13.9 million.
  • Per our database at Business Quant, Pacira BioSciences' Net Income soared by 1,421.01% in 2020 and then crashed by 337.30% in 2024.
  • Yearly analysis of 5 years shows Pacira BioSciences' Net Income stood at $145.5 million in 2020, then crashed by 71.15% to $42.0 million in 2021, then tumbled by 62.10% to $15.9 million in 2022, then soared by 163.72% to $42.0 million in 2023, then tumbled by 337.30% to -$99.6 million in 2024.